Methoserpidine: Difference between revisions
Rabin Bista (talk | contribs) No edit summary |
Rabin Bista (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
| verifiedrevid = 437166703 | | verifiedrevid = 437166703 | ||
|ImageFile=Methoserpidine wiki str.png | |ImageFile=Methoserpidine wiki str.png | ||
|ImageSize=200px | |ImageSize=200px | ||
|IUPACName= | |IUPACName= |
Revision as of 18:30, 15 April 2015
WikiDoc Resources for Methoserpidine |
Articles |
---|
Most recent articles on Methoserpidine Most cited articles on Methoserpidine |
Media |
Powerpoint slides on Methoserpidine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Methoserpidine at Clinical Trials.gov Trial results on Methoserpidine Clinical Trials on Methoserpidine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Methoserpidine NICE Guidance on Methoserpidine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Methoserpidine Discussion groups on Methoserpidine Patient Handouts on Methoserpidine Directions to Hospitals Treating Methoserpidine Risk calculators and risk factors for Methoserpidine
|
Healthcare Provider Resources |
Causes & Risk Factors for Methoserpidine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Methoserpidine is an antihypertensive drug related to reserpine.[1]
References
- ↑ PMID 14452236 (PMID 14452236)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand